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from the fertilized egg in development and assembled into
functional tissues. Functional characteristics and gene ex-
pression patterns are then faithfully maintained in somatic
cell lineages over a lifetime. On the molecular level, tran-
scription factors initiate lineage-specific gene expression
programmmes and epigenetic regulation contributes to sta-
bilization of expression patterns. Epigenetic mechanisms are
essential for maintaining stable cell identities and their dis-
ruption can lead to disease or cellular transformation. Here,
we discuss the role of epigenetic regulation in the early
mouse embryo, which presents a relatively well-understood
system. A number of studies have contributed to the under-
standing of the function of Polycomb group complexes and
the DNA methylation system. The role of many other chro-
matin regulators in development remains largely unexplored.
Albeit the current picture remains incomplete, the view
emerges that multiple epigenetic mechanisms cooperate for
repressing critical developmental regulators. Some chromatin
modificationsappeartoactinparallelandothersmightrepress
the same gene at a different stage of cell differentiation.
Studies in pluripotent mouse embryonic stem cells show that
epigenetic mechanisms function to repress lineage specific
gene expression and prevent extraembryonic differentiation.
Insights into this epigenetic “memory” of the first lineage
decisions help to provide a better understanding of the func-
tion of epigenetic regulation in adult stem cell differentiation.
All cells of an organism are generated from a single fertil-
ized oocyte during development. Cell differentiation is guid-
ed by transcription factors that define expression profiles of
intermediate precursors and the functional differentiated cell
types of the organs and tissues. Mutual antagonism between
lineage-specific transcription factors is thought to establish
distinct cell-type-specific expression patterns (for a detailed
discussion see Graf and Enver 2009). This view is supported
by evidence showing that expression of certain transcription
factors can enforce a dominant cell fate. Demonstrated cell
fate conversions include the generation of muscle cells from
fibroblasts through expression of the transcription factor
Myf5 or the conversion of B cells into macrophages by C/
EBPα expression (Graf and Enver 2009). These findings are
consistent with an instructive role of transcription factors in
the establishment of cell fates.
In addition to transcription factor networks, other mecha-
nisms act to stabilize cell fates once these have been estab-
lished. These mechanisms include small RNAs and
chromatin- or DNA-modifying protein complexes. In mam-
mals, DNA cytosine methylation and chromatin-modifying
complexes of the Polycomb group (PcG) proteins are promi-
nent examples for regulators that repress genes that are inap-
propriate for a certain cell type or lineage. Thereby the
developmental potential of cells within a lineage becomes
progressively restricted in differentiation. The stabilizing ef-
fect of epigenetic restrictions becomes apparent when differ-
entiated cells are reprogrammed to pluripotent stem cells
through the expression of a cocktail of transcription factors
(Orkin and Hochedlinger 2011). Generating induced pluripo-
tent stem (iPS) cells is an inefficient and lengthy process that
possibly highlights the opposing action of epigenetic regula-
tion against cell-type reprogramming (Yamanaka 2009).
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Abstract The distinct cell types of the body are established IntroductionWhen and how epigenetic patterns are established in
development is a focus of current research. Here, we discuss
the present understanding of epigenetic regulation in the
early mouse embryo where a large number of studies have
characterized the establishment of different cell lineages.
The lineages of the early embryo
A number of studies have contributed to the understanding
of patterning and lineage commitment in the mouse embryo
(Arnold and Robertson 2009). Expression of the zygotic
genome commences at the two-cell stage (Fig. 1a,
Hamatani et al. 2004). The trophectoderm (TE) is the first
lineage to differentiate forming the outside cells of the
morula stage embryo (for review see Sasaki 2010).
Position-dependent Hippo signalling activates the transcrip-
tional activity of Tead4 in cells with an outer position in the
embryo. Tead4 induces Cdx2 and Gata3 expression and
thereby initiates TE specification (Ralston et al. 2010).
Differentiation of the TE is then regulated by a transcription
factor network including Eomes and Elf5. In contrast, the
inner cell mass (ICM) cells that give rise to the embryo
express Oct4, Sox2 and Nanog. Antagonism between the
transcription factor networks around Cdx2 and Oct4, which
each positively regulate their own transcription, reinforces
Fig. 1 Epigenetic regulation in early mouse development. a Schematic
representation of mouse development is aligned with key epigenetic
events in panels b and c. The trophectoderm (TE) lineage is the first to
differentiate from cells that have an outside position of morula stage
embryos (red shading). At the blastocyst stage, the hypoblast (green)i s
specified. Inner cell mass cells (yellow) will give rise to the developing
mouse embryo whereas TE and hypoblast form extraembryonic tis-
sues. b Genomic imprints are parent-of-origin-specific marks that are
maintained during embryogenesis and regulate the differential
expression of the maternal and paternal copy of imprinted genes. X
chromosome inactivation and reactivation is observed during develop-
ment of female embryos. c A diagram illustrating global changes in
DNA methylation (5mC) and DNA hydroxymethylation (5hmC) lev-
els. In cleavage stage embryos the paternal (blue lines) and maternal
(red) genomes are differentially marked by 5hmC and 5mC, respec-
tively. Both 5mC and 5hmC levels decrease during development to the
blastocyst stage and then 5mC increases as the embryonic lineages are
formed
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ICM develops into the epiblast and hypoblast (primitive
endoderm; PE) which are determined by transcription fac-
tors Nanog and Gata6, respectively and are further regulated
by MAPK (mitogen-activated protein kinase) signalling
(Chazaud et al. 2006). It has been shown that the formation
of the hypoblast can be suppressed by culturing mouse
embryos with inhibitors of the MAPK pathway (Nichols et
al. 2009), whereas Nanog is required to establish a pluripo-
tent cell fate (Silva et al. 2009). Thus, repeated bifurcations
of cell fates caused by position-dependent cell signalling
and transcriptional feedback loops initiate the formation of
the lineages of the early embryo.
In addition to transcription factors, epigenetic mecha-
nisms contribute to the regulation of gene expression in
the early embryo (Fig. 1b). A number of imprinted genes
are expressed from a single parental allele. Genomic im-
printing implies that information for expression or repres-
sion of a parental allele must be maintained from the
maternal and paternal germlines throughout fertilization
and development. Since diffusible transcription factors have
equal access to both alleles, genomic imprinting is best
explained by a mechanism that links gene regulatory infor-
mation to the DNA or chromatin of the gene locus
(Ferguson-Smith 2011). Epigenetic regulation in cis is also
highlighted by the process of X inactivation in female em-
bryos (Augui et al. 2011). Thereby, the X-linked gene dos-
age is equalized to one active X chromosome between male
(XY) and female (XX) cells. In mice, inactivation of the
paternally inherited X chromosome is initiated at the four-
cell stage (Fig. 1b). Imprinted inactivation of the paternal X
chromosome is maintained in the extraembryonic lineages,
whereas reactivation of the inactive X chromosome (Xi) is
observed in the cells of the ICM that give rise to the epiblast.
In the embryonic lineages, dosage compensation is re-
established at the time of gastrulation by random inactiva-
tion of either the maternally or paternally inherited X chro-
mosome. Notably, neither X inactivation nor genomic
imprinting are essential for development to the blastocyst
stage. Uniparental diploid mouse embryos such as parthe-
nogenotes and androgenotes have been observed to reach
the blastocyst stage and even to implant. Similarly, disrup-
tion of X inactivation by deletion of the Xist gene arrests
development only after implantation (Marahrens et al.
1997). Furthermore, combined disruption of imprinting
and X inactivation in haploid parthenogenotes can be com-
patible with blastocyst development and recently it has been
shown that haploid embryonic stem cells can be established
a n dm a i n t a i n e di nc u l t u r e( E l l i n ge ta l .2011;L e e ba n d
Wutz 2011).
The function of epigenetic regulation has also been elu-
cidated in different stem cell lines of the early embryo that
reflect characteristics of different lineages (Rossant 2007,
Fig. 2a). Trophoblast stem (TS) cells and extraembryonic
endoderm stem (XEN) cells maintain the capacity to differ-
entiate into the trophoblast and primitive endoderm (PE)
lineage, respectively. In both stem cell types, imprinted
inactivation of the paternal X chromosome is observed
(Kunath et al. 2005). Mouse embryonic stem (ES) cells are
derived from the ICM of the blastocyst. ES cells maintain
the potential for differentiating into all cell types of the
embryo, which has been impressively demonstrated by us-
ing tetraploid aggregation (Nagy et al. 1990) or injection of
ES cells into eight-cell embryos (Poueymirou et al. 2007)t o
generate mice whose cells are almost entirely derived from
ES cells. In contrast to their wide lineage potential, ES cells
do normally not contribute to extraembryonic tissues (TE
Fig. 2 Transcriptional control and epigenetic regulation in the lineages
of the mouse blastocyst. a The three lineages of the blastocyst can give
rise to stem cell lines in culture. Transcription factor networks as
observed in trophectoderm stem (TS) cells, extraembryonic endoderm
stem (XEN) cells and ES cells are shown (green) and their mutual
antagonistic regulation is indicated. b Repression of key transcription
factors of extraembryonic lineage development in ES cells has been
analysed. A number of epigenetic regulators contribute to repress
genes and their activity and interactions with chromatin on gene
promoters are summarized in the scheme
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ICM of the late blastocyst and early epiblast. A second
pluripotent stem cell type can be obtained from the mouse
postimplantation epiblast (Brons et al. 2007; Tesar et al.
2007). Similar to ES cells, these epiblast-derived stem cells
(EpiSCs) possess a wide lineage differentiation potential in
culture. However, EpiSCs do not efficiently contribute to
embryogenesis when injected into blastocysts. Furthermore,
EpiSCs have initiated X inactivation whereas female mouse
ES cells possess two active X chromosomes (Guo et al.
2009). This indicates that the two pluripotent cell types are
distinguished by developmental and epigenetic character-
istics. It is interesting to observe that pluripotent stem cells
established from most mammals including humans resemble
the EpiSC type with the notable exception of the rat
(Blair et al. 2011). This could potentially indicate that
the EpiSC cell state is maintained more stably in evolu-
tion. The developmentally restricted differentiation
potential of the stem cells of the early mouse embryo
has been studied for understanding transcriptional and
epigenetic regulation in lineage specification.
The function of epigenetic regulators during early
embryogenesis
In mammals, a number of chromatin- and DNA-
modifying activities have been identified and their func-
tion in development and differentiation has been char-
acterized (Table 1). DNA methylation and chromatin-
modifying activities of the Polycomb group complexes
have been extensively studied and are presently best
understood. A role of other epigenetic regulators such
as the histone methylases G9a and Eset as well as the
DNA hydroxymethylase Tet family of proteins have also
been implicated in development (Fig. 2b). Albeit the
Table 1 Epigenetic modifications and their regulation and function in mouse development
Modification Enzyme/factor Genomic target Function Phenotype of mutation
5mC Dnmt1 CpG island promoters
genomic repeats
Maintenance DNA
methyltransferase
Embryonic lethal at midgestation
and disruption of imprints
Dnmt3a Promoters De novo methylation Postnatal lethality
Dnmt3b Pericentric repeats
promoters
De novo methylation Embryonic lethality after E9.5
Dnmt3L Imprinted genes Recruitment of Dnmts in
germline and early embryo
Imprinting disruption and failure of
gametogenesis
Uhrf1/Np95 Hemimethylated
DNA
Recruits Dnmt1 to hemimethylated
DNA
Embryonic lethal after gastrulation
SmcHD1 Inactive X chromosome Maintenance of gene repression
and DNA methylation on Xi
Female embryonic lethality at midgestation
Combined mutation of Dnmt1, Dnmt3a and Dnmt3b causes loss of genomic 5mC and is compatible with ES cell survival and extraembryonic
development, but not with survival of differentiated embryonic cell types.
5hmC Tet1 Promoters Hydroxymethylation No phenotype
Tet2 Promoters Hematopoietic differentiation Tet2 mutation causes enhanced hematopoietic
progenitor survival and leukaemia
Tet3 Paternal genome 5hmC modification of paternal genome in
preimplantation embryo
Loss of early postimplantation stage
embryos
TDG 5hmC modified DNA Demethylation by base excision repair
pathway
Embryonic lethality before E12.5
Oxidation of 5hmC by the Tet1-4 enzymes is thought to enable demethylation of DNA through base excision by thymidine deglycosylase
(TDG) and subsequent repair.
H3K27me3 PRC2 (Ezh2,
Suz12 and Eed)
Gene promoters LTR
transposons
Repression of developmental
and cell cycle regulators
Lethality after implantation
H2AK119ub PRC1 (Ring1b
and Ring1a)
Gene promoters Repression of developmental
and cell cycle regulators
Ring1b mutation causes gastrulation arrest
Polycomb complexes (PRC1 and PRC2) maintain gene repression of developmental control genes including Hox gene clusters.
They also act on other targets such as the cell cycle regulator p16. Depending on the gene mutation of either complex or combined, loss of
PRC1 and PRC2 functions lead to derepression.
H3K9me3 ESet Gene promoters Gene repression and viral
repression
Early embryonic lethality
G9a/GLP Gene promoters
retrotransposons
Gene and transposon repression
and DNA methylation
Embryonic lethality
Suv39h1 and
Suv39h2
Pericentric
heterochromatin
Maintenance of heterochromatin
and genomic stability
Viable but genomic instability due to
compromised centromere function
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isnotyetcompletetheavailabledataprovidesinsightsintothe
distinct roles of epigenetic regulation in development.
Polycomb complexes
PcG proteins are transcriptional repressors that have a role
in maintaining repression of developmental regulator genes
from plants to mammals (Beisel and Paro 2011). Their
evolutionary origin can be traced back to unicellular organ-
isms (Shaver et al. 2010). In animals, PcG proteins are
widely known for their function in Hox gene regulation.
PcG proteins are components of chromatin-modifying com-
plexes. Polycomb repressive complex 1 (PRC1) catalyses
monoubiquitinylation of histone H2A (ubH2A) and PRC2
mediates di- and tri-methylation of histone H3 lysine 27
(H3K27me2 and H3K27me3). Gene deletion studies in
mice have shown that both PRC1 and PRC2 are essential
for development and their disruption leads to arrest soon
after implantation (O'Carroll et al. 2001;V o n c k e ne ta l .
2003; Wang et al. 2001). Consistent with normal develop-
ment to the blastocyst stage, ES cells have been obtained
that are deficient in PRC1 or PRC2 catalytic activity
(Chamberlain et al. 2008; Leeb and Wutz 2007; Schoeftner
et al. 2006). Surprisingly, these ES cells have the ability to
differentiate into embryonic lineages despite aberrant gene
expression is observed including misregulation of the Hox
gene clusters (Chamberlain et al. 2008;L e e ba n dW u t z
2007). A combined disruption of PRC1 and PRC2 is not
compatible with differentiation suggesting an overlapping
function of both PcG complexes in cell differentiation (Leeb
et al. 2010). Consistent with this idea PRC1 and PRC2
cooperate to repress a number of target genes including
Cdx2, Gata4, Gata6 and Sox7 (Leeb et al. 2010).
PcG regulation in mammals is complex and the number
of PcG genes has expanded during evolution. Especially, the
PRC1 component Ring1b participates in multiple com-
plexes that show a heterogeneous and cell-type-specific
composition. As a consequence, deletions of individual
PcG genes result in complex phenotypes. Whereas deletion
of Eed and Ring1b in ES cells appears to eliminate the
catalytic functions of PRC2 and PRC1, respectively, dele-
tions in Ring1a, Bmi1 or Mel18 have less severe consequen-
ces (Schuettengruber et al. 2007). A partial compensation
for the loss of Ring1b function by Ring1a has also been
described (de Napoles et al. 2004; Stock et al. 2007). Other
proteins have been identified that contribute to the recruit-
ment of PcG complexes or modulate their function. Jarid2
has been identified as a stoichiometric component of the
PRC2 complex in ES cells (Herz and Shilatifard 2010).
Jarid2 has DNA binding activity and modulates PRC2 re-
cruitment to target genes (Li et al. 2010). However, mutation
of Jarid2 does not lead to an upregulation of PcG target
genes (Landeira et al. 2010). Loss of Jarid2 can been
associated with either a loss (Li et al. 2010; Pasini et al.
2010) or increase (Peng et al. 2009; Shen et al. 2009)o f
H3K27me3 on different target genes. Complex regulation is
also suggested by the finding that the enzymatic activity of
PRC1 is not essential for chromatin compaction and gene
repression within the Hoxb locus (Eskeland et al. 2010). The
PcG system involves heterogeneous complexes that distinct-
ly regulate a wide range of different target genes and whose
function is essential after specification of the early embry-
onic lineages.
DNA methylation
In mammals, methylated cytosine is predominantly ob-
served in the context of CpG dinucleotides and is involved
in a range of processes including embryogenesis, genomic
imprinting and tumorigenesis (Bird 2002). CpG methylation
is generally correlated with transcriptional inactivity of pro-
moters. In mice, three DNA methyltransferases Dnmt1,
Dnmt3a and Dnmt3b have been identified (Li et al. 1992;
Okano et al. 1999). Gene deletion studies have provided
insight into the function of DNA methylation in develop-
ment (Table 1). Disruption of Dnmt1 results in lethality
before E 10.5 (Li et al. 1992). Similarly, loss of Dnmt3b is
lethal before E 9.5 (Okano et al. 1999). Although deletion of
Dnmt3a is compatible with embryonic development,
Dnmt3a-deficient mice die within the first weeks after birth
(Okano et al. 1999). Interestingly, the specification and
function of early embryonic lineages is largely unaffected
by loss of DNA methyltransferases. Deficiency for all three
DNA methyltransferases in ES cells leads to a complete loss
of DNA methylation (Tsumura et al. 2006). These ES cells
show increased cell death in differentiation and do not
contribute to embryonic lineages at E 10.5 when injected
into blastocysts. However, they can colonize the ICM and
show limited ability to contribute to chimeric E 8.5 embry-
os. Notably, the extraembryonic lineages can be established
in the absence of DNA methylation, whereas maintenance
of differentiated embryonic cell types is dependent on the
DNA methylation system (Sakaue et al. 2010).
Maintenance of DNA methylation patterns is mediated
by the restoration of symmetrical methylation on hemime-
thylated CpG dinucleotides following DNA replication.
This is facilitated by the Np95/Uhrf1 protein that recruits
Dnmt1 to hemimethylated CpG sites (Bostick et al. 2007;
Sharif et al. 2007). Np95 is required for maintaining DNA
methylation patterns and its disruption in mice leads to
lethality after gastrulation (Sharif et al. 2007). Thus, deletion
of Np95 and Dnmt1 appear to cause similar phenotypes.
Methylated cytosine in DNA can be further modified by
the Tet family of proteins that catalyse the oxidation of 5-
methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC)
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for ES cells (Wu et al. 2011). Tet1 binds preferentially to
CpG-rich sequences at promoters and its activity has been
associated with both activating and repressing functions. It
has been suggested that 5hmC could potentially mask the
silencing effect of 5mC. In addition, 5hmC appears to be
involved in the repression of Polycomb-targeted develop-
mental regulators (Wu et al. 2011). In ES cells, Tet1-
repressed genes include Sox17, Gata6 and Cdx2. In line
with these observations, disruption of Tet1 expression pre-
disposes to differentiation into extraembryonic tissues (Ficz
et al. 2011; Ito et al. 2010). A recent study of Tet1-deficient
mice has shown that Tet1 is dispensable for maintaining
pluripotency and its loss is compatible with embryonic and
postnatal development (Dawlaty et al. 2011). This could
possibly point towards compensation by other Tet family
proteins. Recently, it has been shown that Tet3 is required
for hydroxymethylation of the paternal genome in
zygotes (Gu et al. 2011). In mouse cleavage stage em-
bryos, the paternal genome is largely devoid of 5mC but
enriched in 5hmC, whereas the maternal genome is
marked by 5mC (Iqbal et al. 2011,F i g .1c). Loss of
maternal Tet3 leads to increased developmental failure
after implantation. Both 5hmC and 5mC can be further
oxidized by the Tet dioxygenases to 5-carboxylcytosine
(5acC), which in turn is removed by thymine-DNA
glycosylase thereby establishing a mechanism for DNA
demethylation (He et al. 2011). These findings suggest a
complex chemistry leading to different modification
states of cytosine in DNA and allowing methyl-removal
to unmethylated DNA (Nabel and Kohli 2011). Similar
to chromatin modifications, DNA methylation has to be
understood as a dynamic and reversible modification in
development.
Chromatin-modifying complexes
A large number of chromatin-modifying proteins have
been identified in mice. These contribute to constitutive
heterochromatin on centromeres and telomeres and also
have roles in silencing genomic repeat elements. The
formation of heterochromatin at the pericentric regions
as well as the variation and propagation of epigenetic
states to a dynamic chromatin template have been ex-
tensively studied (reviewed in Fodor et al. 2010). In
addition, several histone methylases and deacetylases
function in development. The histone methyltransferases
G9a and Eset catalyse histone H3 lysine 9 methylation
and contribute to gene regulation in the early embryo.
Deletion of G9a results in embryonic lethality between
E 8.5 and E 9.5 (Tachibana et al. 2002). Mutation of
Eset results in peri-implantation lethality between E 3.5
and E 5.5. Consistent with this early lethality, Eset-
deficient ES cells could not be established (Dodge et
al. 2004) indicating an essential function for Eset in
preimplantation development. Eset mediates di- and tri-
methylation of histone H3lysine9 (H3K9me2/3) (Lohmann
et al. 2010). However, genetic ablation of Eset function
does not result in a global reduction of H3K9me3,
which is possibly explained by the fact that the majority
of H3K9me3 is associated with pericentric heterochro-
matin which depends on the Suv39h1/2 histone methyl-
transferases (Fodor et al. 2010). Deletion of Eset results
in a failure to establish the epiblast due to inappropriate
trophectodermal differentiation (Yeap et al. 2009). The
demonstration that Eset-depleted ES cells can incorporate
into the trophectoderm and differentiate into placental
tissues shows that the lineage restriction of ES cells
towards extraembryonic cell fates depends on Eset func-
tion. One of the Eset target genes in ES cells is Cdx2
(Lohmann et al. 2010) and an interaction between Eset
with Oct4 has been reported (Yeap et al. 2009;Y u a ne t
al. 2009). These findings suggest that Oct4 might recruit
Eset for repression of genes involved in extraembryonic
differentiation. Consistent with this interpretation, loss of
Oct4 and Eset in ES cells are associated with overlap-
ping phenotypes. A critical role of Eset in epiblast
development also explains the inability to establish
Eset-deficient ES cells (Yeap et al. 2009).
The NuRD complex has also been implicated in the
establishment of the epiblast lineage. NuRD is a multi
subunit complex that possesses nucleosome remodelling
and histone deacetylase (HDAC) activity. Interference
with NuRD function by deletion of the Mbd3 gene
abrogates the formation of a normal epiblast possibly
caused by inappropriate trophectodermal differentiation
( K a j ie ta l .2007). However, Mbd3-deficient ES cells
have been derived suggesting that NuRD contributes to
but is not absolutely essential for epiblast establishment.
Mbd3-deficient ES cells can self renew in the absence of
LIF signalling (Kaji et al. 2006). It has been proposed
that in ES cells Mbd3 has an additional function and
might facilitate the exit of pluripotency and entry into
differentiation. Taken together, these findings suggest
that Eset and Mbd3 might directly influence the forma-
tion of the epiblast lineage by preventing extraembryonic
differentiation. This could hint at the molecular basis of
a “memory” of earlier lineage decisions. Alternatively,
these epigenetic regulators might act as co-repressors
together with transcription factors such as the interaction
of Eset with Oct4 suggests. Recently, a genome-wide
study has shown that Tet1 (5hmC) and Mbd3 colocalize
in ES cells (Yildirim et al. 2011). Mbd3 and Tet1
recruitment to many target loci is interdependent indicat-
ing an additional function of Mbd3 in regulating patterns
of DNA hydroxymethylation.
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disruptions
Studies of loss of function situations in mice have contrib-
uted to the understanding of epigenetic regulators in early
embryonic lineage decisions. In some cases, the formation
of blastocysts and implantation were not perturbed by the
loss of epigenetic regulators. However, phenotypic conse-
quences of loss of epigenetic regulators could be masked by
stable transcription factor networks that would keep cell
fates largely intact. This idea is supported by the observation
in cultured ES cells that are deficient in Polycomb complex
activity. These cells can be maintained in culture even if a
large set of genes are misregulated which is advantageous
for investigating epigenetic regulators as cell viability is not
affected. However, several aspects should be considered
when interpreting data in the early embryo. In the preim-
plantation embryo, a delayed phenotype can potentially
also be caused due to partial compensation by a maternal
store of proteins and RNA in the oocytes (Hamatani et al.
2004). An example is Ezh2 which is detected as a ma-
ternally inherited protein in oocytes (Erhardt et al. 2003).
Loss of Ezh2 in oocytes causes growth retardation of
neonates even when zygotic expression from the paternal
allele restores Ezh2 protein at the 4-cell stage. This illus-
trates a distinct function for Ezh2 in oocytes and preim-
plantation embryos. Compensation for phenotypic effects
could also result from the parallel action of more than
one epigenetic system. In this case, the phenotype would
only be observed if simultaneous mutations would be
examined. At present, redundancies between different
chromatin-modifying activities are not completely under-
stood but some could be predicted from overlapping
chromatin targets. In addition, a recent report suggests
that many epigenetic marks remain unknown and are still
to be explored (Tan et al. 2011). Notably, despite of
potential compensation, substantial disruptions in gene
regulation are observed in embryos with mutations in
epigenetic regulators (Leeb et al. 2010). Taken together
with the observation that a lack of dosage compensation
or loss of imprinting can be tolerated by the early mouse
embryo, it is tempting to speculate that the early cell
lineages are characterized by a robustness for maintaining
crucial features of cell types and morphology. At later
stages of development, a multitude of cell interactions are
required for maintaining viability and morphology. This
makes it more difficult to clearly discern the effects of
epigenetic disruptions on gene regulation within tissues
and organs. The early embryonic lineages might, thus,
provide a suitable model to unravel the molecular inter-
actions between transcription and chromatin regulation
for obtaining a framework for the interpretation of experi-
ments in more complex systems.
Establishment of epigenetic patterns
For exploring the targets of epigenetic regulation, genome-
wide analyses of binding sites and chromatin modifications
have been performed in ES cells. More than 2,000 gene
promoters have been found to be bound by PcG proteins
(Boyer et al. 2006; Ku et al. 2008; Mikkelsen et al. 2007).
PcG targets include a number of lineage-specific transcrip-
tion factors suggesting that PcG complexes maintain the
multilineage differentiation potential of ES cells by prevent-
ing activation of differentiation genes. In ES cells, nearly all
PcG target genes are in a bivalent chromatin configuration
comprising tri-methylation of histone H3 lysine 27 and
lysine 4. Furthermore, RNA polymerase II is found in a
non-processive state (Boyer et al. 2006;K ue ta l .2008;
Mikkelsen et al. 2007). It has been suggested that this
special chromatin configuration allows rapid activation of
repressed PcG target genes by developmental cues when
cells enter differentiation into a lineage (Stock et al. 2007).
Indeed upon differentiation, the bivalent state is resolved
to either an H3K27me3- or a H3K4me3-only state
(Bracken et al. 2006; Mohn et al. 2008). Activation of
PcG-repressed target genes involves the Trithorax (TrxG)
group of proteins (Schuettengruber et al. 2007).
Recently, a number of additional activities have been
reported that act in the removal of PcG complexes from
chromatin. The displacement of PcG proteins and acti-
vation of target genes has been reported to be dependent
on serine 28 phosphorylation of histone H3 (Gehani et
al. 2010). In addition, demethylation of H3K27me3 is
catalysed by the UTX demethylase (Seenundun et al.
2010), and the deubiquitination of ubH2A is catalysed
by PR-DUB (Scheuermann et al. 2010). These findings
indicate that the PcG/TrxG targets are regulated by mul-
tiple positive and negative regulators that facilitate the
establishment and removal of PcG repression. PcG pat-
terns are established in a dynamic and lineage-specific
manner in development (Bracken et al. 2006; Mikkelsen
et al. 2007; Mohn et al. 2008), suggesting that keeping a
fine balance between different chromatin regulators is
key to faithfully maintain specific expression patterns.
Genome-wide analysis of DNA methylation in ES cells
(Meissner et al. 2008) has shown little overlap with PcG
target genes suggesting that DNA methylation patterns are
specified independently of PcG complexes. A gain of DNA
methylation was observed during differentiation, consistent
with an early developmental phenotype of mutations in
DNA methyltransferases (Mohn et al. 2008,F i g .1c).
Promoters of several hundred genes become cytosine meth-
ylated in lineage-committed progenitor cells. However, only
few differences between neural progenitors and terminally
differentiated neurons were detected. This observation sug-
gests that methylation of non-lineage genes is already
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restrict the differentiation potential to within the lineage.
Interestingly, many genes that are PcG targets in ES cells
acquire DNA methylation during differentiation indicating a
function of DNA methylation in maintaining the inactive
promoter state when genes are not activated in a certain
lineage (Mohn et al. 2008). It is conceivable that PcG
proteins act in early stages to establish reversible repression
and DNA methyltransferases stabilize gene repression at a
later stage of differentiation. A similar mechanisms has been
proposed in X inactivation where initiation of chromosome-
wide silencing is independent of DNA methylation.
However, maintenance of gene repression on the Xi in
somatic cells requires DNA methylation (Blewitt et al.
2008; Sado et al. 2000). DNA methylation is also required
for regulation of imprinted genes (Li et al. 1993). In addi-
tion, Elf5 is an important target of DNA methylation in ES
cells. Demethylation of Elf5 has been shown to induce
trophectodermal differentiation (Hemberger et al. 2009;N g
et al. 2008). However, DNA methylation is neither essential
for the self renewal of ES cells nor for nuclear reprogram-
ming of somatic cells to a pluripotent state (Pawlak and
Jaenisch 2011).
In contrast to DNA methylation which is underrepresent-
ed on PcG target promoters, 5hmC shows a pronounced
overlap with bivalent PcG-bound chromatin (Williams et
al. 2011). A functional overlap between the 5hmC system
and PcG-mediated gene repression has also been inferred
from data showing that more than 40 % of genes dere-
pressed after Tet1 depletion are also upregulated in Eed-
deficient cells. However, co-binding to the same targets
appears not to be due to a direct biochemical interaction
between Tet and PcG proteins (Pastor et al. 2011). Notably,
Tet1 also has an activating role and overlaps with H3K36me3
on active genes (Wu et al. 2011) suggesting an independent
role of 5hmC in priming genes for activation by maintaining
reversible repression in ES cells by protecting CpG dinucleo-
tides from aberrant DNA methylation (Wu et al. 2011). In
support of this idea, it has been demonstrated that depletion of
Tet1 leads to methylation of the Nanog promoter in ES cells.
Taken together, these findings suggest multiple roles for Tet
proteinsinmodulatinggenerepressionandDNAmethylation.
Albeit transcription factor binding sites are associated
with promoters of several PcG target genes the establish-
ment of epigenetic patterns can hardly be explained by this
overlap alone. It appears that multiple mechanisms specify
chromatin and DNA modifications (Fig. 3). DNA methyla-
tion patterns appear independent of transcription factor net-
works in ES cells and might reflect maintenance of silencing
of genes that have become repressed long ago, such as
imprinted genes that have derived their marking from one
of the parental germlines. However, this general pattern
does not rule out that sequence elements specify the meth-
ylation state. Indeed, it has been shown that DNA sequence
Fig. 3 Transcription factors,
chromatin-modifying com-
plexes and lincRNAs have been
implicated in specifying epige-
netic patterns. Transcription
factors (TFs) activate genes in a
cell-type- or lineage-specific
manner. In addition TFs also
associate with chromatin- or
DNA-modifying activities that
repress certain of their target
genes. Among TF-activated
genes are a class of long non-
coding RNAs (LincRNAs) that
can bind different chromatin
regulators and might function to
target them to certain genomic
regions. Thereby, lincRNAs
provide a mechanism for estab-
lishing epigenetic patterns on
regions that do not have binding
sites for TFs. Repressive chro-
matin marks are important for
preventing activation of genes
associated with other lineages
thereby preventing aberrant
differentiation
258 Chromosoma (2012) 121:251–262elements can specify hypo- or de novo methylation in a
developmental context (Lienert et al. 2011). For some
genes, it is conceivable to construct a logic series from
transcription factors to PcG complexes and on to DNA
methylation. However, binding of PcG proteins is only
partially explained by the binding of core transcription
factors in ES cells. This suggests that other mechanisms
specify epigenetic patterns—the underlying DNA sequence
and 3D chromosome compartmentalization have been sug-
gested. In addition, noncoding RNAs have been observed to
contribute to PcG recruitment. Prominent examples are
HOTAIR in the regulation of the human HOXD gene cluster
(Rinn et al. 2007) and Xist in X inactivation (Mak et al.
2002; Plath et al. 2003). A recent study has systematically
investigated the function of a large number of noncoding
RNAs in ES cells (Guttman et al. 2011). Several of these
lincRNAs bind chromatin-modifying proteins and repress
lineage programmes. Notably, the majority of lincRNAs are
regulated by ES cell transcription factors which suggest that
RNAs could constitute an important class of regulators for
establishing epigenetic patterns in ES cells.
Heritability of epigenetic marks
Establishment of an epigenetic memory requires a mecha-
nism to perpetuate marks during cell division in such a way
that they can be inherited by the descendants within a cell
lineage. How defined patterns of chromatin modifications
are copied to both replicated DNA strands is presently not
fully understood. A mechanism for maintaining DNA meth-
ylation patterns has been suggested. Uhrf1/NP95 binds to
hemimethylated CpG sites and recruits Dnmt1 thereby re-
establishing cytosine methylation on the replicated DNA
strand. It is easy to see how symmetrically methylated
CpG sites can be maintained by this mechanism. For histone
modifications, the situation is more complex. Firstly, the
large variety of histone modifications and their combina-
tions suggest that these marks need to be established by
multiple complexes in a sequential manner. Secondly, his-
tones become displaced during replication from the DNA
strands. Therefore, reassembly of modified histones into
nucleosomes would require precise control mechanisms.
Thirdly, there is evidence suggesting that histone modifica-
tions are not intrinsically stable. An example is the constant
requirement of Xist RNA for recruitment of PcG complexes
to the Xi (Kohlmaier et al. 2004; Pullirsch et al. 2010;
Schoeftner et al. 2006). This could point to a scenario
whereby patterns of modified histones are specified by
complex mechanisms. This leads to the question: What
constitutes a memory mark?
Some work suggests that DNA methylation patterns
and maintenance of hypoacetylated chromatin might
be a stable and heritable configuration (Blewitt et al.
2008; Csankovszki et al. 2001; Pullirsch et al. 2010).
Hypoacetylation of chromatin could be maintained by
recruitment of HDACs which have been reported to
interact with Dnmt1 (Fuks et al. 2000). A function of
HDACs in silencing of PcG target genes has also been
established (Schuettengruber et al. 2007), suggesting
that multiple interactions between chromatin-modifying
activities could provide stability and contribute to the
maintenance of repressed chromatin. This view is sup-
ported by observations that different histone modifica-
tions frequently overlap on important developmental
genes and detailed models for the maintenance of peri-
centric heterochromatin have been developed (Fig. 2b,
Fodor et al. 2010). Mutual reinforcement of silencing by
multiple mechanisms could provide increased stability
and also facilitate modulation by cell signalling in de-
velopment. Future research into the structure of chro-
matin will certainly lead to a better understanding of
this important aspect of gene regulation.
Conclusion and future outlook
The early embryo provides insights into the function of
epigenetic mechanisms in cell differentiation. Epigenetic
modifications appear to have a role in restricting the differ-
entiation potential of cells. How and to which extent chro-
matin modulators interact to maintain gene expression states
remains largely unexplored. It is becoming increasingly
clear that master regulators of lineage identity are co-
regulated by several epigenetic silencing mechanisms in
ES cells. Regulators of extraembryonic lineages including
Gata4, Gata6 and Cdx2 are derepressed in PRC1-, PRC2-,
Mbd3-, Tet1- and Eset-deficient ES cells. Thus, disruption of
single epigenetic systems leads to upregulation of extraem-
bryonic core transcription factors, and, in some cases, aber-
rant differentiation into extraembryonic tissues. The extent
to which chromatin regulators and the DNA methylation
machinery have overlapping functions and how these inter-
act in development will be an important question for future
research.
Notably, ES cell self-renewal can occur in the absence of
certain epigenetic regulators despite substantial misregula-
tion of gene expression. Whilst it appears that epigenetic
regulators perform a function in noise reduction in the gene
expression profile of ES cells, their function becomes criti-
cal upon differentiation for restricting expression pro-
grammmes. This consideration is also important for
understanding epigenetic regulation in adult stem cell sys-
tems. Recent studies have begun to address the function of
PcG proteins in adult stem cells. Notably, in the hematopoi-
etic system, disruption of PRC1 and PRC2 was found
Chromosoma (2012) 121:251–262 259associated with distinct and opposing outcomes in stem cell
proliferation and differentiation (Majewski et al. 2010). This
unexpected result highlights the complexity of blood lineage
formation where homeostatic feedback regulation of prolif-
eration and differentiation contributes to the observed phe-
notypes. In the future, it will be important to construct a
theoretical framework of epigenetic regulation for better
understanding cell-type changes during tissue repair and
reprogramming.
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